A rare autoimmune disorder was behind Mr Hazwady Nazran's paranoid delusions, memory loss and seizures. Read more at ...

Hazwady Nazran, now 38, was hospitalised with mysterious and terrifying symptoms such as violent episodes, paranoid delusions, confusion, memory loss and seizures. If his wife, Dr Miria Hastuti ...

昱展新药(6785)行研发的Ketamine(氯胺酮)缓释注射剂ALA-3000通过美国食品药物管理署(FDA)新药临床试验(IND)申请审查，核准执行于难治型忧郁症(Treatment-resistant depression, TRD)的临床I/IIa期试验。昱展新药开发 ...

Apimostinel has a similar mode of action to ketamine and derivatives like Johnson & Johnson's Spravato (esketamine) – ...

GNT Pharma Co. Ltd, a late-stage pharmaceutical company founded in 1998 with offices in Seoul Korea, Italy and USA, announced today the results of its latest Phase II ('SONIC') and Phase III ('Rodin') ...

Magnesium supplements are having a moment. Videos uploaded with #magnesium have been viewed 1.3 billion times on TikTok.

Relmada Therapeutics will halt two Phase III trials of a major depressive disorder drug after a futility assessment and ...

Relmada halted Phase 3 trials of NMDA receptor blocker for depression but will continue its early psilocybin program while ...

Relmada Therapeutics is a late-stage biotechnology company addressing diseases of the central nervous system (CNS) and metabolic disorders. Relmada’s experienced and dedicated team is committed to ...

The drug candidate is administered as intravenous and subcutaneous infusion. MIJ-821 acts by targeting NR2B. It is developed based on subtype-selective NMDA receptor (SNRMs) technology. It is a new ...

If you're struggling to sleep, you've probably tried many methods to doze off more easily – but one doctor has shared a ...